12:00 AM
 | 
Feb 04, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bronchitol mannitol regulatory update

FDA's Pulmonary-Allergy Drugs Advisory Committee voted 14-0 against approval of an NDA for Bronchitol mannitol from Pharmaxis to improve pulmonary function in cystic fibrosis patients >=6 years of age. The committee also voted 11-3 in 2...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >